5
Press Release - hubergroup India expands its support for rural healthcare
One document
more
Stories about Medizinische Behandlung
The world's first Extended Isolated Stopflow Limb Infusion (EISLI) to treat osteosarcoma results in complete remission
moreBreakthrough - EUR 50 million investment for start-up BrainRepair UG / Pivotal trial on stem cell treatment for brain damage in newborns fully funded
moreCO.DON finally saved - investor has taken over the business operations of the Leipzig-based biopharmacy company with an additional location in Teltow, Brandenburg
Leipzig / Teltow (ots) - CO.DON continues business operations as a GmbH (limited liability company) With effect from 20.01.2023, CO.DON's business activities will be continued in the legal form of a GmbH (limited liability company) following a transferring reorganisation. The asset deal with Rejuvenate GmbH, a ...
moreTechnische Universität München
Nanoswitches for tumor targeting
TECHNICAL UNIVERSITY OF MUNICHCorporate Communications Center phone: +49 89 289 22798 - email: presse@tum.de - web: www.tum.de Video: https://www.youtube.com/watch?v=_xXV0mCke1g NEWS RELEASE Nanoswitches for tumor targeting TUM spin-off Plectonic develops antibody-based immunotherapies Plectonic Biotech, a spin-off of the Technical University of Munich (TUM), has developed a nanoswitch that binds immune cells to tumor cells. The goal is to facilitate the development of ...
moreStem cell therapy for “Butterfly disease” / RHEACELL receives ‘Partners in Progress Award’ from debra of America for Epidermolysis Bullosa research
more
Metrics in Balance und DNA Talks schließen sich zusammen und betreten den europäischen Lifestyle-Markt unter einem neuen Namen: LifeTalks
moreKlinik für Prostata-Therapie Heidelberg
Focal therapy for prostate cancer: Reliable diagnosis leads to gentle treatment
moreEuropean Society for Medical Oncology (ESMO)
ESMO 2022 - Great oaks grow from small acorns: oncology is committed to doing its part for sustainability
Paris (ots) - At ESMO 2022, 9-13 September, Paris, France, the premier cancer congress in Europe, which has gathered 28k participants from 167 countries, many discussions will be around sustainability, prevention and novel approaches which could soon become a reality in the clinic. - Late-breaking results elucidate ...
morebenfovir Announces First Subjects Dosed in Phase 1 Clinical Trial of B-OT/ B-OT IS BEING DEVELOPED FOR THE TREATMENT OF VIRAL INFECTIONS
Darmstadt (ots) - benfovir AG has reached another major milestone by moving its first compound into clinical development with the start of a Phase 1 testing B-OT in healthy volunteers. benfovir AG, a German pharmaceutical biotechnology company focused on developing small molecules against viral infection such as ...
moreTechnische Universität München
Multi-functional bandage helps wounds to heal
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10808- email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/about-tum/news/press-releases/details/37410 Pictures: https://mediatum.ub.tum.de/1659268 NEWS RELEASE Biomolecular film adheres to sensitive tissue and releases active ingredients Multi-functional bandage helps wounds to heal Researchers at the ...
moreTechnische Universität München
A repair program for the heart
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22731 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/about-tum/news/press-releases/details/37376 Images: https://mediatum.ub.tum.de/1658419 NEWS RELEASE A repair program for the heart Cardiac progenitor cells generate healthy tissue after a heart attack Following a heart attack, the human body is incapable of repairing lost tissue due to the heart’s ...
more
Three benefits that make lemon a key food in the Mediterranean diet
moreEndoscopic surgery of herniated discs demonstrates statistically significant pain relief and cost effectiveness compared to open procedures
Munich (ots) - A team of physicians, led by neurosurgeon Dr. B.S. Harhangi from Erasmus Medical Center in Rotterdam, recently published a study demonstrating considerable relief for patients with herniated discs after using the MaxMoreSpine© System. For the first time, a scientific study compares outcome and ...
moreTechnische Universität München
Overcoming resistance of pancreatic cancer to immunotherapies
Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/about-tum/news/press-releases/details/37173 High resolution images: https://mediatum.ub.tum.de/1641984 NEWS RELEASE “Inflaming” cold tumors Overcoming resistance of pancreatic cancer to immunotherapies Pancreatic carcinoma is a ...
moreUniversity of Chicago Clinical Trial Utilizes Sysmex Inostics Highly Effective HPV-SEQ Test to Measure HPV-DNA from Blood of Neck and Throat Cancer Patients
Baltimore, MD (ots) - Sysmex Inostics, a global leader in the liquid biopsy revolution for oncology, announces the use of their HPV-SEQ test in the prospective University of Chicago clinical trial,1 “Pilot Study of Chemotherapy for HPV-Associated Oropharyngeal Cancer.” “The ability to reliably detect HPV-DNA ...
moreALDER HEY AND NEEDLESMART PARTNERSHIP AIMS TO REDUCE 100,000 NEEDLESTICK INJURIES TO NHS HEALTHCARE WORKERS
moreDigital health platform helps to expand conventional medical services / EvoCare invites investors to support global roll-out
more
Almirall delivers solid nine months 2021 results and tightens its upgraded guidance
Barcelona, Spain (ots/PRNewswire) - - Strong Core business performance with growth in Core Net Sales EUR601.7 MM (+6.2% year-on-year) and Core EBITDA reaching EUR164.2 MM, (+20.3% year-on-year) driven by positive contribution from Growth Drivers and a strong EU dermatology performance - Key Growth Drivers underpinning increase in Core Net Sales. Strong performance from ...
moreCPhI worldwide: German probiotics company SYNformulas seeks partnerships to drive internationalization
moreShockwave therapy brings new healing opportunities for heart attack patients and hope for people with spinal cord injuries
Vienna (ots) - Success Story of Extracorporeal Shock Wave Therapy (ESWT) Successful for over 40 years in urology for the disintegration of kidney stones, with high efficiency and hardly any side effects worth mentioning. How does the shock wave work? Without causing mechanical damage, shockwaves trigger a biological ...
moreCPhI worldwide: German probiotics company SYNformulas seeks partnerships to drive internationalization
Press release Combating intestinal complaints and allergies CPhI worldwide: German probiotics company SYNformulas seeks partnerships to drive internationalization - SYNformulas, leading probiotics supplier from Germany, will exhibit for the first time at the pharmaceutical trade fair CPhI worldwide in Milan - Focus ...
moreNew Ultra-Sensitive Leukemia Blood Test Delivered by Sysmex Inostics
moreAlmirall S.A.: Experts highlight the need to focus on psoriasis patients' wellbeing in clinical practice
Barcelona, Spain (ots/PRNewswire) - - Psoriasis affects the overall emotional wellbeing of 88% of patients[1], and at least 20% of psoriasis patients have considered suicide[2] - Currently used endpoints in psoriasis do not capture the full impact of this skin condition on patients' lives, and almost 50% of them ...
more
- 2
#Artificial Intelligence in Healthcare - Sim&Cure Announces the Appointment of Dan Raffi as Chief Operating Officer and Board Member
more Technische Universität München
Messengers from gut to brain
TECHNICAL UNIVERSITY OF MUNICHCorporate Communications Center phone: +49 89 289 22562 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/about-tum/news/press-releases/details/36901 High resolution images: https://mediatum.ub.tum.de/1622134 NEWS RELEASE Messengers from gut to brain Seen for the first time: T cells traveling from the gut and skin to the central nervous system Scientists have long been aware of a link between the gut ...
moreLebrikizumab significantly improved skin clearance and itch in people with moderate-to-severe atopic deramatitis in two Phase 3 trials
Barcelona (ots/PRNewswire) - - Primary and all key secondary endpoints including itch, interference of itch on sleep and quality of life were met at Week 16 in two pivotal Phase 3 trials - Safety profile consistent with prior lebrikizumab studies in atopic dermatitis Lebrikizumab led to significant improvements with ...
moreePresentation of the results of the in-vitro study regarding the anti-proliferative and pro-apoptotic effects of Polyphenon® E (Veregen®) at the 31st German Skin Cancer Congress on 10 September 2021
Strausberg (ots) - Aresus Pharma GmbH, a company of DERMAGO Holding GmbH, announced today that the abstract "Inhibition of cell-proliferation and cell viability by Polyphenon E ® (Veregen®) in cutaneous SCC cell lines" has been accepted as an e-poster short presentation at the 31st German Skin Cancer Congress. In ...
more
2Tianjin Haihe Media Group presents the story of Zhang Boli in fighting COVID-19 with TCM
more
Tianjin Haihe Media Group presents the story of Zhang Boli in fighting COVID-19 with TCM
more
Previous123456Next